A detailed history of Tributary Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tributary Capital Management, LLC holds 6,560 shares of EW stock, worth $429,548. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,560
Previous 6,960 5.75%
Holding current value
$429,548
Previous $665,000 9.02%
% of portfolio
0.05%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$84.3 - $94.31 $33,720 - $37,724
-400 Reduced 5.75%
6,560 $605,000
Q4 2023

Jan 16, 2024

SELL
$61.71 - $77.76 $12,342 - $15,552
-200 Reduced 2.79%
6,960 $530,000
Q3 2023

Oct 11, 2023

SELL
$69.28 - $93.38 $6,928 - $9,338
-100 Reduced 1.38%
7,160 $496,000
Q2 2023

Jul 17, 2023

BUY
$81.41 - $94.33 $211,666 - $245,258
2,600 Added 55.79%
7,260 $684,000
Q1 2023

Apr 26, 2023

SELL
$74.26 - $84.51 $7,426 - $8,451
-100 Reduced 2.1%
4,660 $385,000
Q4 2022

Jan 27, 2023

SELL
$68.3 - $87.44 $6,830 - $8,744
-100 Reduced 2.06%
4,760 $355,000
Q3 2022

Oct 11, 2022

SELL
$82.37 - $107.29 $3,294 - $4,291
-40 Reduced 0.82%
4,860 $402,000
Q2 2022

Jul 19, 2022

SELL
$86.5 - $128.27 $8,650 - $12,827
-100 Reduced 2.0%
4,900 $466,000
Q1 2022

Apr 22, 2022

SELL
$101.96 - $128.34 $20,392 - $25,668
-200 Reduced 3.85%
5,000 $589,000
Q4 2021

Jan 06, 2022

SELL
$106.37 - $130.68 $23,933 - $29,403
-225 Reduced 4.15%
5,200 $674,000
Q3 2021

Oct 14, 2021

SELL
$102.91 - $122.75 $164,656 - $196,400
-1,600 Reduced 22.78%
5,425 $614,000
Q1 2021

Apr 20, 2021

BUY
$78.68 - $90.67 $96,383 - $111,070
1,225 Added 21.12%
7,025 $588,000
Q4 2020

Jan 19, 2021

SELL
$71.69 - $91.23 $10,753 - $13,684
-150 Reduced 2.52%
5,800 $529,000
Q3 2020

Oct 13, 2020

SELL
$67.19 - $87.44 $10,078 - $13,116
-150 Reduced 2.46%
5,950 $475,000
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $228,433 - $305,491
3,970 Added 186.38%
6,100 $422,000
Q1 2020

Apr 14, 2020

SELL
$52.41 - $81.0 $4,192 - $6,480
-80 Reduced 3.62%
2,130 $402,000
Q4 2019

Jan 16, 2020

SELL
$71.7 - $82.09 $656,055 - $751,123
-9,150 Reduced 80.55%
2,210 $516,000
Q3 2019

Oct 15, 2019

SELL
$61.55 - $75.43 $519,482 - $636,629
-8,440 Reduced 42.63%
11,360 $2.5 Million
Q2 2019

Jul 11, 2019

SELL
$55.74 - $64.41 $39,018 - $45,087
-700 Reduced 3.41%
19,800 $3.66 Million
Q1 2019

Apr 17, 2019

BUY
$47.89 - $64.05 $292,129 - $390,705
6,100 Added 42.36%
20,500 $3.92 Million
Q4 2018

Jan 23, 2019

SELL
$46.41 - $56.94 $46,410 - $56,940
-1,000 Reduced 6.49%
14,400 $2.21 Million
Q3 2018

Oct 16, 2018

SELL
$45.7 - $58.03 $18,280 - $23,212
-400 Reduced 2.53%
15,400 $2.68 Million
Q2 2018

Jul 25, 2018

SELL
$42.45 - $51.3 $12,735 - $15,390
-300 Reduced 1.86%
15,800 $2.3 Million
Q1 2018

Apr 19, 2018

SELL
$37.19 - $47.45 $11,157 - $14,235
-300 Reduced 1.83%
16,100 $2.25 Million
Q4 2017

Jan 25, 2018

SELL
$33.79 - $39.39 $195,982 - $228,462
-5,800 Reduced 26.13%
16,400 $1.85 Million
Q3 2017

Oct 19, 2017

BUY
$36.29 - $38.83 $805,638 - $862,026
22,200
22,200 $2.43 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Tributary Capital Management, LLC Portfolio

Follow Tributary Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.